Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
Synapse (New York, N.Y.)|October 17, 1998
Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brainU D McCann, J Yuan, G A RicaurteProgress in Neuro-Psychopharmacology & Biological Psychiatry|November 26, 1998
Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramineU D McCann, V Eligulashvili, G A RicaurteNeuropsychobiology|June 27, 2000
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studiesU D McCann, V Eligulashvili, G A RicaurteNeurology|December 17, 1998
Memory impairment in abstinent MDMA ("Ecstasy") usersK I Bolla, U D McCann, G A RicaurteSleep|September 1, 1993
Persistent effects of (+/- )3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleepR P Allen, U D McCann, G A RicaurteDrug Safety|August 1, 1996
Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')U D McCann, S O Slate, G A RicaurteAddiction (Abingdon, England)|May 1, 1994
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humansT D Steele, U D McCann, G A RicaurteThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: importance of dose, species and drugU D McCann, J Yuan, G Hatzidimitriou, et al.Psychopharmacology|June 15, 1999
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled studyU D McCann, M Mertl, V Eligulashvili, et al.Toxicology Letters|March 18, 2000
Toxicodynamics and long-term toxicity of the recreational drug, 3, 4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')G A Ricaurte, U D McCann, Z Szabo, et al.Pageof 11